The FDA’s new Rare Disease Framework Initiative aims to make rare disease drug reviews more consistent. A public meeting is ...

Roche will propose cancer targets and Hansoh will build antibody-drug conjugates against them, with $400 million upfront and $15B+ in milestones.

After more than a year of threats and six months after President Donald Trump signed a national-security proclamation, U.S. tariffs on imported patented medicines and their ingredients expanded Sept.

Eli Lilly has agreed to acquire AtaiBeckley for $2.8 billion upfront, plus up to $1 billion in contingent value rights, in a deal that could reach $3.8 billion. The acquisition would make Lilly the ...

The FDA has finalized new guidelines for meetings between the FDA and sponsors or applicants relating to the development and review of drugs or biological products under the Prescription Drug User Fee ...

The international biotech sector clocked in at $1.37 trillion in 2022 despite headwinds such as slow launches, long-term drug pricing shifts and changing consumer behavior. Recent biotech ...

At its recent annual Science Day, Moderna signalled a strategic expansion beyond its established vaccine and rare disease franchises, unveiling new programs in in vivo CAR-T and solid tumor oncology.

Earendil Labs and NewLimit round out the top three slots in the ranking below, which is limited to private biotechs that announced or disclosed financing between Jan. 1 and Aug. 12, 2026. Earendil ...

As the biotech industry matures, several North American cities are emerging biotech hubs, aiming to become the next epicenters of innovation and growth. While traditional hubs like Boston and San ...

Could the genetic secrets of “extreme mammals” help unlock treatments for myriad human diseases? The Emeryville, California–based startup Fauna Bio is betting on that premise. One of the animals the ...

While San Francisco, Boston, and San Diego may reign as biotech royalty, a new contender is carving its niche in the desert. Las Vegas, a city synonymous with entertainment and extravagance, is ...

Bristol Myers Squibb said Monday it will deploy an NVIDIA DGX SuperPOD, a prepackaged supercomputing platform that NVIDIA sells as a single standard unit, combining multiple compute racks, high-speed ...